Gareth Thomas – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Gareth Thomas on 2016-02-03.

To ask the Secretary of State for Health, what steps he plans to take in response to increases in the cost to the NHS of Liothyronine; and if he will make a statement.

George Freeman

The Government’s policy on generic medicines is to allow manufacturers freedom of pricing for their products, relying on competition to deliver value for money. Any potential pricing abuses are a matter for the Competition and Markets Authority (CMA). The Department is in regular contact with the CMA.